HemoShear Therapeutics, LLC

Closed

HemoShear Therapeutics, LLC is a biotech company in Charlottesville, United States, founded in 2015. It has raised $44.0M across 3 rounds, most recently a $40.0M Series A in July 2025.

hemoshear.com

Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$44.0M
Last Round
$40.0M Series AJul 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat rare metabolic disorders, particularly in children with genetic liver defects. Using proprietary tissue-based disease modeling technology, HemoShear recapitulates diseases in vitro to interrogate disrupted biochemical processes and identify drug candidates. The company has collaboration agreements with Pfizer and Horizon Therapeutics.

Summary

It lists 11–50 employees. It has raised $44.0M in total across 3 rounds, most recently a $40.0M Series A round in Jul 2025. Investors include Janus Henderson Investors and Adage Capital.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJul 2025
$40.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HemoShear Therapeutics, LLC on Indexed.vc
<a href="https://indexed.vc/companies/hemoshear-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/hemoshear-therapeutics-llc" alt="HemoShear Therapeutics, LLC on Indexed.vc" width="260" height="76" /></a>